LY2940680

DRUG3 trials

Sponsors

Eli Lilly and Company

Conditions

Medulloblastoma, ChildhoodNeoplasm MetastasisRhabdomyosarcomaSmall Cell Lung Carcinoma

Phase 1

A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma

WithdrawnNCT01697514

Eli Lilly and CompanyMedulloblastoma, Childhood, Rhabdomyosarcoma

Start: 2013-07-31End: 2016-07-31Updated: 2013-08-27

A Study of LY2940680 in Small Cell Lung Cancer

TerminatedNCT01722292

Eli Lilly and CompanySmall Cell Lung Carcinoma

Start: 2013-01-31End: 2015-02-28Updated: 2018-12-28

A Study of LY2940680 in Japanese Participants With Advanced Cancers

CompletedNCT01919398

Eli Lilly and CompanyNeoplasm Metastasis

Start: 2013-08-31End: 2017-06-28Updated: 2019-09-11